YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
8.80
+0.38 (4.45%)
Feb 26, 2026, 4:00 PM EST - Market closed
YD Bio Revenue
In the year 2024, YD Bio had annual revenue of $510.36K with 45.76% growth. YD Bio had revenue of $142.69K in the quarter ending December 31, 2024, with 95.63% growth.
Revenue (ttm)
$510.36K
Revenue Growth
+45.76%
P/S Ratio
1,237.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
620.94M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.36K | 160.23K | 45.76% |
| Dec 31, 2023 | 350.13K | -13.99K | -3.84% |
| Dec 31, 2022 | 364.12K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionYDES News
- 1 day ago - YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform - GlobeNewsWire
- 4 weeks ago - YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy - GlobeNewsWire
- 7 weeks ago - YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development - GlobeNewsWire
- 7 weeks ago - YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap - GlobeNewsWire
- 2 months ago - YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center - GlobeNewsWire
- 2 months ago - YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN - GlobeNewsWire
- 3 months ago - YD Bio Limited Expands OkaiDx™ Testing Portfolio to Pancreatic and Colorectal Cancer Detection Across the U.S. and Provides Clinical Research Update on Pancreatic Cancer Early Detection - GlobeNewsWire
- 3 months ago - YD Bio Limited Announces U.S. Ophthalmology Market Entry, Advances Across Diagnostics and LSC Exosome Therapeutics - GlobeNewsWire